Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/7/2025

Myeloid Leukemia Associated with Down Syndrome

Classification and Recognition

  • The World Health Organization (WHO) classification specifically lists "Myeloid leukemia associated with Down syndrome" as a distinct entity under "Myeloid proliferations related to Down syndrome" 1, 4
  • This classification also includes "Transient abnormal myelopoiesis" (also called transient myeloproliferative disorder), which is unique to newborns with Down syndrome 2, 3
  • These conditions are considered separate from other types of Acute Myeloid Leukemia (AML) due to their unique clinical, biological, and genetic features 4

Clinical Management

  • The American Academy of Pediatrics recommends that babies with Down syndrome undergo complete blood count screening to detect transient myelodysplasia of the newborn 5
  • Referral to a pediatric hematologist/oncologist is recommended due to the significantly higher risk of developing leukemia compared to the general population 5